Procurement

NHS NOFE and Midlands & East Branded Medicines - Tranche A- 1 September 2026

NHS England

Procurement identifier (OCID): ocds-h6vhtk-051c98

Description

NHS Branded Framework Agreement - Lot 1 - Tranche A for the North of England and Midlands & East.

Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority's discretion for a further 24 months.

Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement : 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.

Notices

UK2: Preliminary market engagement notice

Notice identifier: 2026/S 000-002508
Published: 13 January 2026, 9:57am

UK1: Pipeline notice

Notice identifier: 2025/S 000-029473
Published: 3 June 2025, 12:41pm

Show all versions